Liu Sha, Dong Wenhong, Gao Hui-Quan, Song Zhaorui, Cheng Zhen
School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China.
Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, Shandong 264117, China.
Acc Chem Res. 2025 Feb 18;58(4):543-554. doi: 10.1021/acs.accounts.4c00671. Epub 2025 Feb 5.
Biomarkers play a vital role in the regulation of life processes, especially in predicting the occurrence and development of diseases. For the early diagnosis and precise treatment of diseases, it has become necessary and significant to detect biomarkers with sensitivity, accuracy, simplicity, convenience, and even visualization. Fluorescent-probe-based techniques have been recognized as one of the most powerful tools for the sensitive detection and real time imaging of biomarkers in biological samples. However, traditional optical probes, mainly including the visible probes (400-700 nm) and the near-infrared I (NIR-I, 700-900 nm) probes, suffer from low sensitivity, poor resolution, strong absorption and scattering, and high background fluorescence, which hinder effective monitoring of biomarkers. Fortunately, the past decade has witnessed a remarkable evolution in the application fields of near-infrared II (NIR-II, 900-1700 nm) fluorescence, driven by its exceptional optical characteristics and the advancement of imaging technologies. Leveraging the superior penetration capabilities, negligible autofluorescence, and extended fluorescence emission wavelengths, NIR-II fluorescent probes significantly enhance the signal-to-noise ratio (SNR) of detection (IVD) and the temporal resolution of imaging. Our team has been committed to the design strategy, controlled synthesis, luminous mechanisms, and biomedical applications of NIR-II fluorescent probes. In this Account, we present the representative works in recent years from our group in the field of NIR-II fluorescent probes for analytical applications, ranging from detection of biomarkers to imaging monitoring of different biomarkers and various diseases, which also will further provide a general overview of analytical applications of NIR-II fluorescence probes. First, the analytical applications of NIR-II fluorescent probes are fully summarized, including tumor marker detection, virus and bacteria analysis, cell testing, and small-molecule sensing. Second, the imaging monitoring applications of NIR-II fluorescent probes are adequately discussed, including ROS detection, gas monitoring, pH sensing, small-molecule testing, receptor analysis, and the imaging diagnosis of some serious diseases. Finally, we further outline the application advantages of NIR-II fluorescent probes in analytical fields and also discuss in detail some challenges as well as their future development. There is a reasonable prospect that the detection technology and the imaging monitoring technology based on NIR-II fluorescent probes will exhibit great development potential in biomedical research and clinical disease diagnosis. We hope that this Account can expand their reach into an even broader spectrum of fields, further enhancing their impact on scientific discovery and medical practice.
生物标志物在生命过程的调节中起着至关重要的作用,尤其是在预测疾病的发生和发展方面。对于疾病的早期诊断和精准治疗,以灵敏、准确、简单、便捷甚至可视化的方式检测生物标志物已变得必要且具有重要意义。基于荧光探针的技术已被公认为是对生物样品中的生物标志物进行灵敏检测和实时成像的最强大工具之一。然而,传统的光学探针,主要包括可见光探针(400 - 700 nm)和近红外I(NIR-I,700 - 900 nm)探针,存在灵敏度低、分辨率差、吸收和散射强以及背景荧光高等问题,这阻碍了对生物标志物的有效监测。幸运的是,在近红外II(NIR-II,900 - 1700 nm)荧光的应用领域,过去十年见证了显著的发展,这得益于其卓越的光学特性和成像技术的进步。利用其优越的穿透能力、可忽略不计的自发荧光以及更长的荧光发射波长,NIR-II荧光探针显著提高了检测(IVD)的信噪比(SNR)和成像的时间分辨率。我们团队一直致力于NIR-II荧光探针的设计策略、可控合成、发光机制及生物医学应用。在这篇综述中,我们展示了近年来我们团队在NIR-II荧光探针用于分析应用领域的代表性工作,从生物标志物的检测到不同生物标志物及各种疾病的成像监测,这也将进一步概述NIR-II荧光探针的分析应用。首先,全面总结了NIR-II荧光探针的分析应用,包括肿瘤标志物检测、病毒和细菌分析、细胞检测以及小分子传感。其次,充分讨论了NIR-II荧光探针的成像监测应用,包括活性氧检测、气体监测、pH传感、小分子检测、受体分析以及一些严重疾病的成像诊断。最后,我们进一步概述了NIR-II荧光探针在分析领域的应用优势,并详细讨论了一些挑战及其未来发展。基于NIR-II荧光探针的检测技术和成像监测技术在生物医学研究和临床疾病诊断中展现出巨大的发展潜力,这是一个合理的展望。我们希望这篇综述能够将它们的应用范围扩展到更广泛的领域,进一步增强它们对科学发现和医学实践的影响。